Heidi Mäkinen

1.7k total citations
19 papers, 682 citations indexed

About

Heidi Mäkinen is a scholar working on Rheumatology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Heidi Mäkinen has authored 19 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Rheumatology, 5 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in Heidi Mäkinen's work include Rheumatoid Arthritis Research and Therapies (16 papers), Systemic Lupus Erythematosus Research (9 papers) and HER2/EGFR in Cancer Research (3 papers). Heidi Mäkinen is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (16 papers), Systemic Lupus Erythematosus Research (9 papers) and HER2/EGFR in Cancer Research (3 papers). Heidi Mäkinen collaborates with scholars based in Finland, United States and United Kingdom. Heidi Mäkinen's co-authors include Tuulikki Sokka, Pekka Hannonen, Hannu Kautiainen, Theodore Pincus, Timo Möttönen, Markku Korpela, Marjatta Leirisalo‐Repo, Harri Blåfield, Mikko Hakola and Leena Laasonen and has published in prestigious journals such as Annals of the Rheumatic Diseases, Archives of Physical Medicine and Rehabilitation and Lara D. Veeken.

In The Last Decade

Heidi Mäkinen

18 papers receiving 645 citations

Peers

Heidi Mäkinen
C McClinton United Kingdom
B Gömör Hungary
I. H. Nuver-Zwart Netherlands
S. ten Wolde Netherlands
K. Lheritier Switzerland
T M Hansen Denmark
Ruth Klaasen Netherlands
P Hickling United Kingdom
Heidi Mäkinen
Citations per year, relative to Heidi Mäkinen Heidi Mäkinen (= 1×) peers Esmeralda T. H. Molenaar

Countries citing papers authored by Heidi Mäkinen

Since Specialization
Citations

This map shows the geographic impact of Heidi Mäkinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Mäkinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Mäkinen more than expected).

Fields of papers citing papers by Heidi Mäkinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi Mäkinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Mäkinen. The network helps show where Heidi Mäkinen may publish in the future.

Co-authorship network of co-authors of Heidi Mäkinen

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Mäkinen. A scholar is included among the top collaborators of Heidi Mäkinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Mäkinen. Heidi Mäkinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Smolen, Josef S, Sabine Collaud Basset, Maarten Boers, et al.. (2016). Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease. Annals of the Rheumatic Diseases. 75(7). 1268–1271. 23 indexed citations
2.
Hirvonen, Jouni, et al.. (2015). OP0025-PARE Campaign Against the Shortage of Rheumatology Professionals. Annals of the Rheumatic Diseases. 74. 74–74. 4 indexed citations
3.
Mäkinen, Heidi, K. Kaarela, Heini Huhtala, et al.. (2012). Do the 2010 ACR/EULAR or ACR 1987 classification criteria predict erosive disease in early arthritis?. Annals of the Rheumatic Diseases. 72(5). 745–747. 8 indexed citations
4.
Sokka, Tuulikki, Pekka Hannonen, & Heidi Mäkinen. (2011). Remission: a realistic goal in rheumatoid arthritis?. International Journal of Clinical Rheumatology. 6(6). 643–647. 3 indexed citations
5.
Möttönen, Timo, Heidi Mäkinen, & Kari Puolakka. (2010). [The goal for the treatment of rheumatoid arthritis should be remission].. PubMed. 126(12). 1457–64. 1 indexed citations
6.
Sokka, Tuulikki & Heidi Mäkinen. (2009). Drug management of early rheumatoid arthritis – 2008. Best Practice & Research Clinical Rheumatology. 23(1). 93–102. 17 indexed citations
7.
Mäkinen, Heidi & Pekka Hannonen. (2009). Dr. Mäkinen and Dr. Hannonen reply. The Journal of Rheumatology. 36(9). 2125.1–2125. 1 indexed citations
8.
Häkkinen, Arja, Heidi Mäkinen, Jari Ylinen, et al.. (2008). Stability of the upper neck during isometric neck exercises in rheumatoid arthritis patients with atlantoaxial disorders. Scandinavian Journal of Rheumatology. 37(5). 343–347. 2 indexed citations
9.
Mäkinen, Heidi, Hannu Kautiainen, Pekka Hannonen, & Tuulikki Sokka. (2008). A new disease activity index for rheumatoid arthritis: Mean Overall Index for Rheumatoid Arthritis (MOI-RA).. PubMed. 35(8). 1522–7. 12 indexed citations
10.
Sokka, Tuulikki, Hannu Kautiainen, S. Toloza, et al.. (2007). QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Annals of the Rheumatic Diseases. 66(11). 1491–1496. 159 indexed citations
11.
Sokka, Tuulikki, Heidi Mäkinen, Pekka Hannonen, & Theodore Pincus. (2007). Most people over age 50 in the general population do not meet ACR remission criteria or OMERACT minimal disease activity criteria for rheumatoid arthritis. Lara D. Veeken. 46(6). 1020–1023. 47 indexed citations
12.
Sokka, Tuulikki, Heidi Mäkinen, Kari Puolakka, Timo Möttönen, & Pekka Hannonen. (2007). Remission as the treatment goal--the FIN-RACo trial.. PubMed. 24(6 Suppl 43). S–74. 16 indexed citations
13.
Mäkinen, Heidi, Hannu Kautiainen, Pekka Hannonen, et al.. (2007). Disease activity score 28 as an instrument to measure disease activity in patients with early rheumatoid arthritis.. PubMed. 34(10). 1987–91. 33 indexed citations
14.
Mäkinen, Heidi, Hannu Kautiainen, Pekka Hannonen, et al.. (2007). Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis.. PubMed. 34(2). 316–21. 97 indexed citations
15.
Mäkinen, Heidi, Pekka Hannonen, & Tuulikki Sokka. (2007). Definitions of remission for rheumatoid arthritis and review of selected clinical cohorts and randomised clinical trials for the rate of remission.. PubMed. 24(6 Suppl 43). S–22. 55 indexed citations
16.
Sokka, Tuulikki, Heidi Mäkinen, Merete Lund Hetland, et al.. (2006). A multinational cross-sectional database to assess clinical status of patients with rheumatoid arthritis (QUEST-RA). VinaR (Institute of Nuclear Sciences "Vinča").
17.
Häkkinen, Arja, Marko H. Neva, Markku Kauppi, et al.. (2005). Decreased Muscle Strength and Mobility of the Neck in Patients With Rheumatoid Arthritis and Atlantoaxial Disorders. Archives of Physical Medicine and Rehabilitation. 86(8). 1603–1608. 9 indexed citations
18.
Mäkinen, Heidi, et al.. (2005). Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?. Annals of the Rheumatic Diseases. 64(10). 1410–1413. 166 indexed citations
19.
Mäkinen, Heidi, Hannu Kautiainen, Pekka Hannonen, & Tuulikki Sokka. (2005). Frequency of remissions in early rheumatoid arthritis defined by 3 sets of criteria. a 5-year followup study.. PubMed. 32(5). 796–800. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026